A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™) Baha M Sibai, M.D., Viveca Odlind, Mary.

Slides:

Advertisements

Similar presentations

Periodontal disease and endometriosis: analysis of the National Health and Nutrition Examination Survey Shahryar K. Kavoussi, M.D., M.P.H., Brady T.

Advertisements

J.C. Trussell, M.D., Allen R. Kunselman, M.A., Richard S. Legro, M.D.

Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization Martin D. Keltz,

Antagonists in poor-responder patients

Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial Tasuku Harada,

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Ronit Machtinger, M.D., Joseph.

Suggestion/Placebo Effects on Pain

Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study Nikos Vlahos, M.D., Athanasios.

Evaluation of basal estradiol levels in assisted reproductive technology cycles2 John L Frattarelli, M.D., Paul A Bergh, M.D., Michael R Drews, M.D.,

Why consider vaginal drug administration?

Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis Paolo Vercellini, M.D., Giussy Barbara, M.D., Edgardo Somigliana,

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives George Mastorakos,

Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter,

Michael M. Alper, M.D. Fertility and Sterility

Periodontal disease and endometriosis: analysis of the National Health and Nutrition Examination Survey Shahryar K. Kavoussi, M.D., M.P.H., Brady T.

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Pharmacokinetic overview of Ortho Evra™/Evra™

Sanghoon Lee, M. D. , Elke Heytens, Ph. D. , Fred Moy, Ph. D

Lisa L. Amsterdam, M. D. , William Gentry, M. D. , Smeta Jobanputra, M

Lauren Groskaufmanis, M.P.H., Saba W. Masho, M.D.

Initial experience with a risk-sharing in vitro fertilization–embryo transfer program with novel features Jacques P. Stassart, M.D., Romaine B. Bayless,

In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors Ahmad O. Hammoud, M.D.,

Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain David S. Guzick, M.D.,

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers Andrea.

Modified natural cycle in in vitro fertilization

Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial Tasuku Harada, M.D., Mikio.

Oocyte cryopreservation

Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral.

Remembering Gary D. Hodgen, Ph.D.: 1943–2005

Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort.

The effects of extended oral contraceptive pills for cycle regulation among different ages and FSH levels prior to ART J.D. Parker, J.H. Segars, A.Y.

The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer Jane T. Hickok, MD, MPH, Joseph A. Roscoe,

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Helen Sullivan,

Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer.

Initial IVF-ET experience with assisted hatching performed 3 days after retrieval followed by day 5 embryo transfer Margaret C. Graham, M.S., Kathleen.

Katherine D. LaGuardia, M. D. , M. P. H. , Alan C. Fisher, Dr. P. H

A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone

Effect of Salpingectomy on Ovarian Reserve: A Systematic Review and Meta-Analysis C.E. Boots, MD, E.A. Seidler, MD, A. Ainsworth, MD, A. Hardi, MLIS,

Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence Jeffrey T. Jensen, M.D.,

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

From partner's desk to iPad

Anne R. Davis, M. D. , Robin Kroll, M. D. , Barbara Soltes, M. D

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis Rina Agrawal,

Trends and outcomes of gestational surrogacy in the United States

“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss Michelle.

Jeanne M Manson, Ph. D. , Mary D Sammel, Ellen W Freeman, Ph. D

Left upper quadrant cannula insertion

Regulation of assisted reproductive technologies in the United States

Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization–embryo transfer cycle outcome Eric S Surrey,

Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D.

Karen L. Margolis, M. D. , Hans-Olov Adami, M. D. , Juhua Luo, M. S

Fertility and Sterility: an evaluation

Oocyte donor screening: the selection process and cost analysis

Oral contraceptives improve lung mechanics

Percutaneous oocyte retrieval from an inguinal ovary

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Luteal phase support Fertility and Sterility

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Tubal sterilization: focus on the U.S. experience

José E. Arjona, M. D. , Ph. D. , Mónica Miño, M. D. , Ph. D

William R. Boone, Ph. D. , Jeffrey M. Jones, Ph. D. , Sander S

Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest Inka Wiegratz, Ph.D.,

Randomized controlled trial: effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization Irene Moy, M.D., Magdy P. Milad, M.D.,

Early pregnancy loss in in vitro fertilization (IVF) is a positive predictor of subsequent IVF success G.Wright Bates, M.D., Elizabeth S Ginsburg, M.D.

Infertility induced by cancer treatment: inappropriate or no information provided to majority of French survivors of cancer Julien Mancini, M.D., M.P.H.,

Daniel R. Grow, M.D., Khosro Iromloo, M.D. Fertility and Sterility

Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data Miriam Zieman, M.D., John Guillebaud,

Hulusi B Zeyneloglu, M.D., Aydin Arici, M.D., David L Olive, M.D.

The cumulative probability of liveborn multiples after in vitro fertilization: a cohort study of more than 10,000 women Beth A. Malizia, M.D., Laura.

Presentation transcript:

A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™) Baha M Sibai, M.D., Viveca Odlind, Mary L Meador, M.D., Gary A Shangold, M.D., Alan C Fisher, Dr.P.H., George W Creasy, M.D. Fertility and Sterility Volume 77, Pages 19-26 (February 2002) DOI: 10.1016/S0015-0282(01)03264-2

FIGURE 1 Participants with breast symptoms, reported by cycle, in the contraceptive patch and oral contraceptive groups. “Breast symptoms” includes breast discomfort, engorgement, and pain. Sibai. Contraceptive patch safety and tolerability. Fertil Steril 2002. Fertility and Sterility 2002 77, 19-26DOI: (10.1016/S0015-0282(01)03264-2)

FIGURE 2 Participants with breast symptoms, reported by cycle, in the pooled analysis. “Breast symptoms” includes breast discomfort, engorgement, and pain. Sibai. Contraceptive patch safety and tolerability. Fertil Steril 2002. Fertility and Sterility 2002 77, 19-26DOI: (10.1016/S0015-0282(01)03264-2)